I Compared 10 of the Cheapest GLP-1 Programs So You Don’t Waste Money on the Wrong One

The mistake most people make when shopping for a GLP-1 program is comparing the medication price alone. The real cost includes shipping, monthly platform fees, required lab work, and whether your doctor actually reviews anything or just rubber-stamps a form. I went through the numbers on ten programs. Here is what I found.

1. HealthRX

This is my top pick for cash-pay affordability, and the reasoning is pretty simple. Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Free overnight shipping to all 50 states. There is no membership fee on top of that. A board-certified physician reads through your intake form and responds within about a day. That is a genuinely low all-in number compared to most of the field.

What separates HealthRX from the cheaper-looking options that turn out to be sketchy: the pharmacy is named. Manifest Pharmacy in Greer, South Carolina is a 503A-registered compounding pharmacy operating under USP-797 standards with lot-level tracking from preparation to delivery. The program is LegitScript-certified (certificate 50087439). That level of supply-chain transparency is not universal in this space.

One honest caveat: compounded GLP-1s are not FDA-approved finished drugs, and HealthRX makes no claim that they are. The clinical weight-loss data it references (around 15% body weight loss at 68 weeks for semaglutide in STEP 1 trials, around 21% at 72 weeks for tirzepatide in SURMOUNT-1) comes from the original pharmaceutical trials, not from HealthRX’s own outcomes. Worth keeping that distinction in mind.

For someone who wants a low cash price, a named and credentialed pharmacy, and fast shipping to any state, this is the clearest value in the list.

2. Mochi Health

Mochi uses board-certified obesity-medicine physicians, which is a meaningful difference from platforms that use general practitioners or NPs for quick sign-offs. Compounded semaglutide is priced at roughly $99 per month and tirzepatide at roughly $199. The monitoring is closer to actual obesity care than most telehealth programs offer.

3. FormBlends

FormBlends earns a spot here for a specific type of buyer. It is a compounded GLP-1 telehealth option with physician oversight, dispensed through an FDA-registered 503A compounding pharmacy. The standout feature is published third-party testing data per vial: HPLC purity percentages, mass spec identity confirmation, and endotoxin/sterility results with actual numbers attached. Most GLP-1 telehealth brands do not publish that.

It also carries a broader catalog of compounded peptides (recovery, longevity, and cognitive categories) under the same clinical model, which matters if you want to work with one provider for more than just weight loss.

The honest tradeoff: semaglutide is around $299 and tirzepatide around $349, which is meaningfully higher than HealthRX’s entry pricing. Ships to 47 states, not all 50. For someone who prioritizes documented purity testing over lowest price, or who wants GLP-1s alongside a peptide catalog, FormBlends makes sense. Pure price shoppers should start elsewhere on this list.

4. Henry Meds

Henry runs on cash-pay compounded GLP-1s with pricing starting around $179 to $249 for the first month. Shipping is fast, often 24 to 72 hours. Monitoring is lighter than Mochi’s, which cuts cost but also cuts oversight. Good option if you want quick access without heavy coaching overhead.

5. Eden

Eden’s compounded semaglutide starts around $149 a month. The intake and prescribing process is online. It is a straightforward option without a lot of extras, which keeps the price down. Not the deepest clinical experience, but the price-to-access ratio is solid for people who already understand what they are taking.

6. MEDVi

Compounded GLP-1s starting around $179 for the first month, no contracts required. The no-contract structure is genuinely useful because it removes the lock-in risk that makes some longer programs feel like a trap if the medication does not work for you.

7. Sesame

Sesame works differently from the others. It is primarily a marketplace for telehealth visits, with GLP-1 prescriptions available from around $59 a month on an annual plan. Medications are billed separately. If you already know what you want prescribed and just need a low-cost visit to get there, Sesame can be the cheapest path. The tradeoff is less built-in continuity of care.

8. WeightWatchers Clinic

The program fee runs around $74 a month, with medications billed on top of that. The WW brand brings behavioral and community infrastructure, which some people find genuinely helpful for long-term habits. If you are someone who struggled with the isolation of purely app-based programs, the combination is worth the higher total cost.

9. PlushCare

Membership is around $19.99 a month. PlushCare focuses on branded medications and takes insurance for them, with same-day visits available. If you have insurance coverage that could apply, this is the first place to check before going the compounded cash-pay route. The insurance navigation can get branded Wegovy or Zepbound to near-zero cost for qualifying patients.

10. Hims & Hers

After the March 2026 Novo Nordisk compounding agreement, Hims moved away from compounded GLP-1s toward branded medications. Injectable Wegovy now runs around $299 a month through their platform, with oral options around $249. It is a more expensive baseline than the compounded programs above, but the brand name and wide recognition make it a common first stop. Insurance and savings cards can pull that cost significantly lower for some patients.

A note before you act on anything here: none of this is medical advice, and GLP-1 medications have real side effects and contraindications that a physician needs to evaluate. The prices listed reflect publicly available information as of mid-2026 and can change. Compounded medications carry different regulatory status than FDA-approved finished drugs.

Common Questions

Is compounded semaglutide from programs like HealthRX or Eden actually the same drug as Ozempic?

No. Compounded semaglutide contains the same active molecule but is not the same product. It is mixed at a 503A pharmacy, not manufactured by Novo Nordisk, and has not gone through FDA approval as a finished drug. The clinical trial results cited by these programs come from branded semaglutide studies, not from the compounded versions.

Why does FormBlends cost so much more than HealthRX if both use compounded GLP-1s?

FormBlends publishes per-vial third-party lab data, including HPLC purity figures, mass spec identity confirmation, and endotoxin results. That testing infrastructure and documentation adds cost. HealthRX competes on price and named-pharmacy transparency instead. Neither approach is wrong; they are targeting different priorities.

Does Mochi Health’s obesity-medicine physician model actually change anything for patients compared to a standard NP sign-off?

It can. Board-certified obesity-medicine physicians are trained to evaluate metabolic history, medication interactions, and dosing in more depth than a general practitioner doing a quick telehealth review. Whether that difference matters for you depends on your health history, but it is a real credential distinction, not just a marketing one.

If I have insurance, should I even bother with the cash-pay compounded programs on this list?

Probably not first. PlushCare works with insurance and can get branded Wegovy or Zepbound to near-zero out-of-pocket for qualifying patients. The cash-pay compounded programs make the most sense when insurance denies coverage or when the branded drug cost after insurance is still higher than $99 to $149 a month.

What happened to Hims & Hers compounded tirzepatide after the March 2026 Novo Nordisk agreement?

The March 2026 agreement specifically involved Novo Nordisk and semaglutide compounding. Hims shifted toward branded Wegovy as a result. Their current injectable pricing sits around $299 a month. Patients who want tirzepatide-based options at lower cash prices are more likely to find them through programs like HealthRX or Mochi that still offer compounded tirzepatide.

Sources

• FDA: 503A compounding pharmacy regulations and 2026 warning letters (FDA.gov)
• SURMOUNT-1 trial data: Jastreboff et al., *New England Journal of Medicine*, 2022
• STEP 1 trial data: Wilding et al., *New England Journal of Medicine*, 2021
• LegitScript certification registry (LegitScript.com)
• Novo Nordisk public statement regarding the compounding settlement, March 2026
• LillyDirect pricing announcement, April 2026 (Eli Lilly investor and consumer communications)